Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
Bimodal-visible lesions more often harbored csPCa and were easier to target. TRUS-visibility of MRI lesions is an independent predictor of csPCa. Therefore, education in both modalities is essential. Despite MRI, the ultrasound should still be diligently examined.
Authors
- Markus Graefen (ORCID: https://orcid.org/0000-0003-3609-3512)
- Fabian Falkenbach (ORCID: https://orcid.org/0000-0003-1907-3982)
- Mykyta Kachanov (ORCID: https://orcid.org/0000-0001-6543-0309)
- Daniel Köehler (ORCID: https://orcid.org/0000-0003-2940-7050)
- Tobias Maurer (ORCID: https://orcid.org/0000-0002-5660-7691)
- Gernot Ortner (ORCID: https://orcid.org/0000-0002-2454-6599)
- Francesca Ambrosini
- Dirk Beyersdorff
- Lars Budäus
- Fatima Ahmad‐Sterkau
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Martini-Klinik (DE)
- Ospedale Policlinico San Martino (IT)
Publication Details
- Journal
- The Prostate
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/pros.24785
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26